[경영]The lack of Pharmaceutical R&D capability in Korea

소개글

즐거운 하루

Korean pharmaceutical industry에 대한 영문 레포트 입니다.

목차

Executive Summary
Table of Contents
List of Table and Figures
1. Introduction
1.1 Aim
1.2 Scope
1.3 Methods
1.4 Plan
1.5 Background
2. Findings and Discussion
2.1 The causes of pharmaceutical R&D insufficiency
2.1.1 Aspect of the Korean pharmaceutical company
2.1.1.1 Low ratio of investment
2.1.1.2 Insufficiency research staff
2.1.2 Korean government policy
2.2 The effects of pharmaceutical R&D insufficiency
2.2.1 Slow development of the Korean pharmaceutical industry
2.2.2 Healthcare budget crisis
3. Conclusion
4. Recommendations
4.1 Merge and acquisition of local pharmaceutical companies
4.2 Partnership with public research center
4.3 Pharmaceutical policy reform to promote foreign investment
5. Appendices
6. References


List of Tables and Figures

List of Tables

Table 1 R&D expenditure of major Korean pharmaceutical companies

List of Figures

Figure 1 Korean pharmaceutical employees in 1999
Figure 2 The rate of research staff in 1999
Figure 3 The rate of investment in G7 countries in 1999
Figure 4 Trade situation of medicines in 2004-2005
Figure 5 Trend of National healthcare expenditure

본문내용

Currently, the 10th largest in the world, the Korean pharmaceutical market was over 8 billion US$ as well as growing about 7%-10% annually (Gross, 2000) However, in term of the pharmaceutical R&D, Korean pharmaceutical sector still lags behind the G7 countries. Base on these facts, the aim of this report analyzes problems of the Korean pharmaceutical R&D between 1995 and 2005. Firstly, this report presents three main causes: 1) low rate of investment from the Korean pharmaceutical companies; 2) Insufficient of research staff; 3) Korean government policy. Furthermore, it also shows the effect such as slow development of local pharmaceutical market and national healthcare budget crisis. Recommendation, which consist of main three solutions provide the Korean Ministry of Health and Welfare to solve the pharmaceutical R&D problems. The information is based on sources from Korean government, National healthcare corporations and academic journals.

참고 자료

Korea Pharmaceutical Manufactures Association, 2001, ‘21st century, Development method of Pharmaceutical industry’, [Online], Available: http://www.kpma.or.kr/kpma/Kor/E01_DataBoard/databoard.asp?cmd=view&act=tpl&bid=e01_databoard&id=8096&mcode, [2006, August 21]

Robert, C. 2003, ‘What Ails the Pharmaceutical Market’, Biopharma business development. [Online]. Available: www.vignette.com/Downloads/WP_PH1_ WhatAilsPharma.pdf, [2006, August 22]

Kim,Y.B. 1989, ‘Innovation Strategy of Local Pharmaceutical Firms in Korea: A Multivariate Analysis’, Technology Analysis and Strategic Management, Vol.1,No.1, [Online], Available: www.mihr.org/?q=filestore/download/269, [2006, August 24]

Diwan, N. nd, ‘Emerging Trends in World Pharmaceutical Market’, National Institute of Pharmaceutical Education and Research, [Online], Availble: www.touchbriefings.com/pdf/890/PT04_Chawla.pdf, [2006, August 21]

Ernst and Young, 2001, ‘Pharmaceutical Industry R&D Costs: Key Findings about the public citizen report’, [Online], Available: www.cptech.org/ip /health /econ/phrmaresponse.pdf, [2006. September 3]

Pharmabiz.com, 2002, May 23, ‘Korean pharmaceutical market’, Pharmabiz.com, [Online], Available: http://www.pharmabiz.com/article/detnews.asp?articleid= 16462 & sectionid=50, [2006, September, 4]

Lee,S.W. 2002, ‘Situation of Pharmaceutical R&D and research fellows in South Korea’, Korea Health Industry Development Institute, [Online], Available: http://www.khidi.or.kr/, [2006, August 22]

Scherer, F.M. nd, ‘The link between gross profitability and Pharmaceutical R&D spending’, Health Affairs, Vol. 20, No. 5, [Online], Available: http://content. healthaffairs.org/cgi/reprint/20/5/216.pdf, [2006, September 5]

Pharma Koreana, 2006, ‘Korea Pharmaceutical news and report’, Vol.16, No.5, [Online], Available: http://www.pharmakoreana.com/, [2006, August 29]

Gross, A. 2000, ‘2000 Regulatory update: South Korea’s Pharmaceutical Market’, Pacific Bridge, [Online], Available: www.pacificbridgemedical.com/ publications/South_Korea_pharmaceutical_regulatory_update_2000.pdf, [2006, September 5]

Moo,K.U, 2005, Spetember 25, ‘Deficit of National Healthcare expenditure’, KookMin newpaper, [Online], Available: http://news.media.daum.net/society/ affair/ 200608/27/ kukinews/v13817596.html, [2006, September 3]

KBS Global new, 2006, September 4, ‘Positive List system and Korea-US’, KBS Global new, [Online], Available: http://english.kbs.co.kr/news/zoom/1407800 _11781.html, [2006, September 3]